Medical Technology SPAC VIDA FLaSH Acquisitions files for a $175 million IPO

LOS ANGELES, Feb. 18, 2021 (GLOBE NEWSWIRE) — VIDA FLaSH Acquisitions (“Vida FLaSH”), a blank check company that seeks to identify and acquire a company in the medical technologies, diagnostics, digital health or genomics fields, announced today that it has filed a registration statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission for a proposed initial public offering of 17,500,000 units at a price of $10.00 per unit, each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share. At the proposed deal size, Vida FLaSH will command a market value of $175 million.

Vida FLaSH was founded in January 2021 and plans to apply to list its units, Class A ordinary shares and warrants on the Nasdaq Capital Market under the symbols FLSHU, FLSH and FLSHW, respectively.  Goldman Sachs is the sole bookrunner on the deal.

The proposed offering will be made only by means of a prospectus, which forms a part of the Registration Statement. Copies of the preliminary prospectus relating to the proposed offering may be obtained, when available, for free by visiting EDGAR on the SEC’s website at www.sec.gov.

Alternatively, copies of the preliminary prospectus, when available, may be obtained from Goldman Sachs & Co LLC, 200 West Street, New York, NY 10282, Attn: Prospectus Department, by telephone at 866-471-2526, facsimile at 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk factors” section of the Registration Statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

John Blake
Chief Financial Officer
VIDA FLaSH Acquisitions
310-954-1575

SOURCE: Globe Newswire, 18th February 2021